Logo
x

Search category

Subscribe Now

Evaluate

Turning Point and EQRx Collaborate to Evaluate Elzovantinib + Aumolertinib in Patients with EGFR Mutant Met-Amplified Advanced NSCLC

Turning Point and EQRx Collaborate to Evaluate Elzovantinib + Aumolertinib in Patients with EGFR Mutant Met-Amplified Advanced NSC...

  • October 14, 2021
Asieris Receives NMPA's IND Approval to Evaluate APL-1202 + Tislelizumab as Neoadjuvant Therapy for MIBC Patients

Asieris Receives NMPA's IND Approval to Evaluate APL-1202 + Tislelizumab as Neoadjuvant Therapy for MIBC Patients

  • October 14, 2021
Sanofi Signs a Non-Exclusive Clinical Collaboration Agreement with Mirati to Evaluate Adagrasib + SAR442720 (RMC-4630) in P-I/II Study for KRAS G12C-Mutated Lung Cancer

Sanofi Signs a Non-Exclusive Clinical Collaboration Agreement with Mirati to Evaluate Adagrasib + SAR442720 (RMC-4630) in P-I/II S...

  • October 8, 2021
Grifols to Evaluate New Immunoglobulin Therapy Against COVID-19 in Spain

Grifols to Evaluate New Immunoglobulin Therapy Against COVID-19 in Spain

  • January 19, 2021
Gilead Collaborates with VIR to Evaluate Combination Therapy for Chronic Hepatitis B Virus

Gilead Collaborates with VIR to Evaluate Combination Therapy for Chronic Hepatitis B Virus

  • January 13, 2021
GSK and VIR Biotechnology to Evaluate VIR-7832 in the Early Treatment of COVID-19

GSK and VIR Biotechnology to Evaluate VIR-7832 in the Early Treatment of COVID-19

  • January 12, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.